We have previously shown that, in RA patients, CD8+CD28− Tregs are dysfunctional due to defective suppressor function and/or the reduced responsiveness of target cells to suppression, which can be corrected by anti-TNF therapy [33]. Here, CD8A is linked to rheumatoid arthritis.